Variant report
Variant | rs11870381 |
---|---|
Chromosome Location | chr17:19957952-19957953 |
allele | A/G |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:61)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr17:19957951-19958001 | H1-hESC | embryonic stem cell: | embryo |
2 | chr17:19957951-19958001 | HRPEpiC | eye: | n/a |
3 | chr17:19957951-19958001 | ovcar-3 | ovarian: | n/a |
4 | chr17:19957951-19958001 | GM19239 | blood: | n/a |
5 | chr17:19957951-19958001 | HCF | heart: | n/a |
6 | chr17:19957951-19958001 | SK-N-SH | brain: | n/a |
7 | chr17:19957951-19958001 | CMK | blood: | n/a |
8 | chr17:19957951-19958001 | Hela-S3 | cervix: | n/a |
9 | chr17:19957951-19958001 | K562 | blood: | n/a |
10 | chr17:19957951-19958001 | GM06990 | blood: | n/a |
11 | chr17:19957951-19958001 | HRE | kidney: | n/a |
12 | chr17:19957951-19958001 | HCT-116 | colon: | n/a |
13 | chr17:19957951-19958001 | AG09319 | gingival: | n/a |
14 | chr17:19957951-19958001 | Caco-2 | colon: | n/a |
15 | chr17:19957951-19958001 | HL-60 | blood: | n/a |
16 | chr17:19957951-19958001 | AG10803 | skin: | n/a |
17 | chr17:19957951-19958001 | NHBE | bronchial: | n/a |
18 | chr17:19957951-19958001 | A549 | lung: | n/a |
19 | chr17:19957951-19958001 | HNPCEpiC | eye: | n/a |
20 | chr17:19957951-19958001 | NT2-D1 | testis: | n/a |
21 | chr17:19957951-19958001 | HPAEpiC | pulmonary alveolar: | n/a |
22 | chr17:19957951-19958001 | ProgFib | skin: | n/a |
23 | chr17:19957951-19958001 | PANC-1 | pancreas: | n/a |
24 | chr17:19957951-19958001 | NH-A | brain: | n/a |
25 | chr17:19957951-19958001 | AG09309 | skin: | n/a |
26 | chr17:19957951-19958001 | AG04450 | lung: | fetal |
27 | chr17:19957951-19958001 | HEK293 | kidney: | embryo |
28 | chr17:19957951-19958001 | GM12878 | blood: | n/a |
29 | chr17:19957951-19958001 | U87 | brain: | n/a |
30 | chr17:19957951-19958001 | HRCEpiC | kidney: | n/a |
31 | chr17:19957951-19958001 | Hepatocyte | liver: | n/a |
32 | chr17:19957951-19958001 | BE2_C | brain: | n/a |
33 | chr17:19957951-19958001 | NB4 | blood: | n/a |
34 | chr17:19957951-19958001 | NHDF-neo | bronchial: | n/a |
35 | chr17:19957951-19958001 | PFSK-1 | brain: | n/a |
36 | chr17:19957951-19958001 | AoSMC | blood vessel: | n/a |
37 | chr17:19957951-19958001 | HCPEpiC | choroid plexus: | n/a |
38 | chr17:19957951-19958001 | T-47D | breast: | n/a |
39 | chr17:19957951-19958001 | SAEC | small airway: | n/a |
40 | chr17:19957951-19958001 | HMEC | breast: | n/a |
41 | chr17:19957951-19958001 | RPTEC | kidney: | n/a |
42 | chr17:19957951-19958001 | HEEpiC | esophagus: | n/a |
43 | chr17:19957951-19958001 | GM12892 | blood: | n/a |
44 | chr17:19957951-19958001 | ECC-1 | luminal epithelium: | n/a |
45 | chr17:19957951-19958001 | HCM | heart: | n/a |
46 | chr17:19957951-19958001 | HUVEC | blood vessel: | n/a |
47 | chr17:19957951-19958001 | PrEC | prostate: | n/a |
48 | chr17:19957951-19958001 | BJ | skin: | n/a |
49 | chr17:19957951-19958001 | SKMC | muscle: | n/a |
50 | chr17:19957951-19958001 | Jurkat | blood: | n/a |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000225681 | CpG island |
ENSG00000128487 | Chromatin interaction |
ENSG00000261033 | Chromatin interaction |
rs_ID | r2[population] |
---|---|
rs11204422 | 0.86[CHB][hapmap];1.00[JPT][hapmap];0.88[ASN][1000 genomes] |
rs11867585 | 0.90[JPT][hapmap] |
rs11867646 | 1.00[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs11867652 | 1.00[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs11868146 | 1.00[CEU][hapmap];1.00[EUR][1000 genomes] |
rs11869931 | 0.83[AFR][1000 genomes];0.88[ASN][1000 genomes] |
rs11870578 | 1.00[CEU][hapmap];1.00[EUR][1000 genomes] |
rs11870673 | 0.95[AFR][1000 genomes];1.00[EUR][1000 genomes];0.96[ASN][1000 genomes] |
rs12451216 | 0.86[ASN][1000 genomes] |
rs12451841 | 1.00[JPT][hapmap];0.86[ASN][1000 genomes] |
rs12453332 | 0.86[AFR][1000 genomes];0.84[ASN][1000 genomes] |
rs12942179 | 0.90[JPT][hapmap];0.88[ASN][1000 genomes] |
rs12947713 | 0.86[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.83[AFR][1000 genomes];0.88[ASN][1000 genomes] |
rs12949710 | 0.83[AFR][1000 genomes];0.88[ASN][1000 genomes] |
rs1468953 | 0.86[AFR][1000 genomes];0.88[ASN][1000 genomes] |
rs1638526 | 0.90[JPT][hapmap] |
rs17685923 | 0.83[AFR][1000 genomes];0.88[ASN][1000 genomes] |
rs17686798 | 1.00[JPT][hapmap];0.83[ASN][1000 genomes] |
rs17759959 | 1.00[JPT][hapmap];0.85[ASN][1000 genomes] |
rs2072337 | 0.90[JPT][hapmap] |
rs28424266 | 0.90[JPT][hapmap] |
rs34370440 | 0.86[ASN][1000 genomes] |
rs34756775 | 0.83[AFR][1000 genomes];0.88[ASN][1000 genomes] |
rs35041742 | 0.80[ASN][1000 genomes] |
rs35124809 | 0.88[ASN][1000 genomes] |
rs35156798 | 0.86[AFR][1000 genomes];0.84[ASN][1000 genomes] |
rs35191778 | 0.86[AFR][1000 genomes];0.88[ASN][1000 genomes] |
rs35244101 | 0.83[AFR][1000 genomes];0.88[ASN][1000 genomes] |
rs35493088 | 0.83[AFR][1000 genomes];0.88[ASN][1000 genomes] |
rs35770292 | 0.85[ASN][1000 genomes] |
rs36051592 | 0.82[ASN][1000 genomes] |
rs3940274 | 0.83[ASN][1000 genomes] |
rs4141185 | 0.90[JPT][hapmap] |
rs4341795 | 0.83[AFR][1000 genomes];0.88[ASN][1000 genomes] |
rs4346259 | 0.83[AFR][1000 genomes];0.88[ASN][1000 genomes] |
rs4350625 | 0.83[AFR][1000 genomes];0.88[ASN][1000 genomes] |
rs4471741 | 0.81[AFR][1000 genomes];0.88[ASN][1000 genomes] |
rs4570919 | 0.90[JPT][hapmap] |
rs4924808 | 1.00[JPT][hapmap];0.86[ASN][1000 genomes] |
rs4925075 | 0.86[CHB][hapmap];1.00[JPT][hapmap];0.95[LWK][hapmap];1.00[YRI][hapmap];0.86[AFR][1000 genomes];0.88[ASN][1000 genomes] |
rs4925076 | 0.83[AFR][1000 genomes];0.88[ASN][1000 genomes] |
rs4925078 | 0.83[AFR][1000 genomes];0.88[ASN][1000 genomes] |
rs4925082 | 0.86[CHB][hapmap];1.00[JPT][hapmap];0.87[ASN][1000 genomes] |
rs4925088 | 0.82[JPT][hapmap] |
rs57146223 | 0.91[ASN][1000 genomes] |
rs60496867 | 0.92[EUR][1000 genomes] |
rs62067488 | 0.86[AFR][1000 genomes];0.88[ASN][1000 genomes] |
rs6587207 | 0.86[CHB][hapmap];1.00[JPT][hapmap] |
rs7207459 | 0.86[CHB][hapmap];1.00[JPT][hapmap] |
rs7209653 | 0.90[JPT][hapmap] |
rs7215803 | 0.86[CHB][hapmap];1.00[JPT][hapmap];0.88[ASN][1000 genomes] |
rs7219688 | 1.00[AMR][1000 genomes];1.00[EUR][1000 genomes] |
rs7223984 | 1.00[EUR][1000 genomes] |
rs7224875 | 0.86[CHB][hapmap];1.00[JPT][hapmap] |
rs7225249 | 0.90[JPT][hapmap];0.88[ASN][1000 genomes] |
rs73981864 | 0.94[EUR][1000 genomes] |
rs7503407 | 0.83[AFR][1000 genomes];0.88[ASN][1000 genomes] |
rs8066705 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs8068484 | 0.86[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.83[AFR][1000 genomes];0.87[ASN][1000 genomes] |
rs8074791 | 1.00[AFR][1000 genomes];1.00[AMR][1000 genomes];1.00[EUR][1000 genomes];1.00[ASN][1000 genomes] |
rs8075343 | 0.86[CHB][hapmap];1.00[JPT][hapmap];1.00[YRI][hapmap];0.83[AFR][1000 genomes];0.88[ASN][1000 genomes] |
rs8080190 | 0.86[CHB][hapmap];1.00[JPT][hapmap] |
rs8081817 | 0.82[AFR][1000 genomes];0.88[ASN][1000 genomes] |
rs888424 | 0.86[CHB][hapmap];1.00[JPT][hapmap];0.88[ASN][1000 genomes] |
rs972966 | 0.83[ASN][1000 genomes] |
rs9897653 | 0.90[JPT][hapmap] |
rs9899251 | 1.00[CEU][hapmap];0.94[EUR][1000 genomes] |
rs9901125 | 0.86[ASN][1000 genomes] |
rs9901294 | 0.90[JPT][hapmap] |
rs9915039 | 0.86[CHB][hapmap];1.00[JPT][hapmap] |
rs9944451 | 0.90[JPT][hapmap] |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | nsv1062853 | chr17:19547912-20206601 | Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Genic enhancers Strong transcription ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer Active TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 63 gene(s) | inside rSNPs | diseases |
2 | nsv907868 | chr17:19768924-20217122 | Enhancers Flanking Active TSS ZNF genes & repeats Strong transcription Weak transcription Active TSS Genic enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNAmiRNA target site | 25 gene(s) | inside rSNPs | diseases |
3 | nsv833394 | chr17:19827714-19999577 | Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Weak transcription Strong transcription Genic enhancers Active TSS Bivalent/Poised TSS ZNF genes & repeats Bivalent Enhancer Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 13 gene(s) | inside rSNPs | diseases |
4 | nsv1060337 | chr17:19828636-20204872 | Active TSS Weak transcription Flanking Active TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Genic enhancers Strong transcription ZNF genes & repeats Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 21 gene(s) | inside rSNPs | diseases |
5 | nsv543257 | chr17:19828636-20204872 | Enhancers Weak transcription Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Genic enhancers Strong transcription Active TSS ZNF genes & repeats Bivalent/Poised TSS Bivalent Enhancer | TF binding regionCpG islandChromatin interactive regionlncRNA | 21 gene(s) | inside rSNPs | diseases |
6 | nsv907870 | chr17:19871922-20001612 | Enhancers Flanking Active TSS Strong transcription Weak transcription Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Bivalent/Poised TSS Genic enhancers ZNF genes & repeats Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 12 gene(s) | inside rSNPs | diseases |
7 | nsv907871 | chr17:19927699-20088492 | Active TSS ZNF genes & repeats Genic enhancers Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Strong transcription Bivalent/Poised TSS Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 11 gene(s) | inside rSNPs | diseases |
8 | nsv482438 | chr17:19934376-20089005 | Enhancers Weak transcription Bivalent/Poised TSS ZNF genes & repeats Flanking Active TSS Bivalent Enhancer Active TSS Flanking Bivalent TSS/Enh Genic enhancers Strong transcription Transcr. at gene 5' and 3' | TF binding regionCpG islandChromatin interactive regionlncRNA | 11 gene(s) | inside rSNPs | diseases |
9 | nsv907872 | chr17:19945841-19996140 | Enhancers Weak transcription Flanking Active TSS ZNF genes & repeats Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Genic enhancers Strong transcription Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 4 gene(s) | inside rSNPs | diseases |
10 | nsv1056224 | chr17:19946604-19993026 | Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS Bivalent/Poised TSS Strong transcription Genic enhancers ZNF genes & repeats Flanking Bivalent TSS/Enh | TF binding regionCpG islandChromatin interactive regionlncRNA | 4 gene(s) | inside rSNPs | diseases |
11 | nsv543258 | chr17:19946604-19993026 | Weak transcription Bivalent Enhancer Enhancers Active TSS Genic enhancers Flanking Active TSS ZNF genes & repeats Bivalent/Poised TSS Flanking Bivalent TSS/Enh Strong transcription | TF binding regionCpG islandChromatin interactive regionlncRNA | 4 gene(s) | inside rSNPs | diseases |
12 | nsv1066594 | chr17:19947874-19986671 | Weak transcription Flanking Active TSS Enhancers Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer ZNF genes & repeats Strong transcription Bivalent/Poised TSS Genic enhancers | TF binding regionCpG islandChromatin interactive regionlncRNA | 3 gene(s) | inside rSNPs | diseases |
13 | nsv543259 | chr17:19947874-19986671 | Active TSS Flanking Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh ZNF genes & repeats Strong transcription Genic enhancers Bivalent/Poised TSS | TF binding regionCpG islandChromatin interactive regionlncRNA | 3 gene(s) | inside rSNPs | diseases |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr17:19943800-19965800 | Weak transcription | Aorta | Aorta |
2 | chr17:19948200-19966400 | Weak transcription | Brain Angular Gyrus | brain |
3 | chr17:19950800-19966400 | Weak transcription | Brain Inferior Temporal Lobe | brain |
4 | chr17:19957000-19962600 | Weak transcription | K562 | blood |
5 | chr17:19957000-19965800 | Weak transcription | Ovary | ovary |
6 | chr17:19957000-19967000 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
7 | chr17:19957200-19962600 | Weak transcription | Primary monocytes fromperipheralblood | blood |
8 | chr17:19957200-19962800 | Weak transcription | Brain Hippocampus Middle | brain |
9 | chr17:19957400-19961000 | Weak transcription | A549 | lung |
10 | chr17:19957400-19962600 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
11 | chr17:19957400-19963000 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |